Empowering the immune system 
Combatting disease with novel nanoimmunotherapeutics that target trained immunity
Trained immunity, a de facto innate immune memory, describes the process by which innate immune system activation results in enhanced responsiveness to subsequent triggers. Trained immunity naturally occurs through mechanistic epigenetic and metabolic reprogramming of innate immune cells. Our research focuses on how this immunological phenomenon can be purposefully induced or downregulated using our novel nanoimmunotherapeutics, as an approach to treating maladies including cancer, bacterial/viral infection, cardiovascular diseases, autoimmune disorders, and allograft rejection in organ transplantation. Through widespread collaboration with other leading researchers in the cutting-edge field of trained immunity, we continue to explore therapy regimens in which our nanoimmunotherapeutics can lead to improved clinical outcomes. 
Mulder NRDD-17-245 Figure 5 cropped.jpeg